Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 45 and 85 years old
- You have been diagnosed with Parkinson's Disease
- You have scored 37 or higher on a scale that measures apathy or motivation levels (confirm with trial site)
- Your Parkinson's medications have not changed recently and are considered stable
- You have a family member, friend, or caregiver who can provide information about you as part of the study
Who may not be able to join:
- You have a medical reason why you cannot safely have an MRI scan or a brain stimulation procedure called TMS (confirm with trial site)
- You have significant memory or thinking difficulties, based on a standard cognitive test score below 21
- You have been diagnosed with certain mental health conditions, including bipolar disorder, schizophrenia, or a current substance use disorder
- You have a history of seizures or epilepsy
- You have had recent thoughts of ending your life or have made a suicide attempt in the past year, based on a standard safety assessment
- You are currently pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
TMS adherence; Frequency and Severity of TMS-Induced Side effects (TMS tolerability and acceptability); Apathy severity as measured by the Lille Apathy Rating Scale; Target engagement (dmPFC network modulation)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.